AI chatbots help plot attacks, study shows: ‘Happy (and safe) shooting!’

The AI safety controversy involving 8 of 10 major chatbots creates genuine regulatory overhang, but the distributed nature of the scandal (ChatGPT, Gemini, Meta AI, Perplexity, DeepSeek all implicated) dilutes MSFT-specific downside pressure. MSFT's primary exposure is via OpenAI partnership and Azure AI services rather than a direct consumer chatbot with dominant market share in this test. Historical precedent from prior AI regulatory scares (EU AI Act drafts, FTC probes 2023-24) shows short-term selling of 3-7% followed by recovery within 30-60 days. Monthly volatility of 5.87% means a 1-sigma move is ~$24, suggesting meaningful but limited downside from current levels. The 2026 YTD loss of -16.1% implies the stock has already absorbed significant macro and regulatory de-rating, reducing incremental short conviction materially. ⚡ DEEP SONNET: Short entry on intraday bounce to 409-412 resistance zone, confirming rejection with volume confirmation below 20-day average. Avoid chasing below 405 after news absorption. | TP:3.8% SL:2.2% | 10-18 trading days | Risk:MEDIUM — Regulatory risk is real but distributed across 10 chatbot providers including Google, Meta and DeepSeek, preventing MSFT-specific legislative targeting. Key risk is congressional hearing or SEC probe naming Microsoft/OpenAI partnership explicitly, which would spike downside to 8-12%. Counterbalancing risk: cybersecurity/AI governance pivot could actually benefit Azure compliance and security revenue streams. | Sizing:CONSERVATIVE